Arkolith/Insider Trading/NRXP/Form 4/A

Hurvitz Chaim

DirectorNRX Pharmaceuticals, Inc. (NRXP) · full profile →Form 4/A · filed Nov 23, 2022
Net Buying
Open-Market Buys
$515K
Open-Market Sells
$0
Net Open-Market Flow
$515K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2022Buy(P)40K$1.10$44K500K
Nov 17, 2022Buy(P)172K$1.08$186K460K
Nov 16, 2022Buy(P)288K$0.99$285K288K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000950142-22-003250) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for NRX Pharmaceuticals, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp